170 related articles for article (PubMed ID: 28249241)
1. Biophenols pharmacology against the amyloidogenic activity in Alzheimer's disease.
Omar SH
Biomed Pharmacother; 2017 May; 89():396-413. PubMed ID: 28249241
[TBL] [Abstract][Full Text] [Related]
2. Olive Biophenols Reduces Alzheimer's Pathology in SH-SY5Y Cells and APPswe Mice.
Omar SH; Scott CJ; Hamlin AS; Obied HK
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30598025
[TBL] [Abstract][Full Text] [Related]
3. The protective role of plant biophenols in mechanisms of Alzheimer's disease.
Omar SH; Scott CJ; Hamlin AS; Obied HK
J Nutr Biochem; 2017 Sep; 47():1-20. PubMed ID: 28301805
[TBL] [Abstract][Full Text] [Related]
4. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
Pinheiro L; Faustino C
Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
7. Biophenols: Enzymes (β-secretase, Cholinesterases, histone deacetylase and tyrosinase) inhibitors from olive (Olea europaea L.).
Omar SH; Scott CJ; Hamlin AS; Obied HK
Fitoterapia; 2018 Jul; 128():118-129. PubMed ID: 29772299
[TBL] [Abstract][Full Text] [Related]
8. Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral Amyloidosis.
Yamada M; Ono K; Hamaguchi T; Noguchi-Shinohara M
Adv Exp Med Biol; 2015; 863():79-94. PubMed ID: 26092627
[TBL] [Abstract][Full Text] [Related]
9. Potential therapeutic implications of gelsolin in Alzheimer's disease.
Ji L; Zhao X; Hua Z
J Alzheimers Dis; 2015; 44(1):13-25. PubMed ID: 25208622
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
Chu J; Lauretti E; Craige CP; Praticò D
J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
[TBL] [Abstract][Full Text] [Related]
11. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
[TBL] [Abstract][Full Text] [Related]
12. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic insights into the role of amyloid-β in innate immunity.
Prosswimmer T; Heng A; Daggett V
Sci Rep; 2024 Mar; 14(1):5376. PubMed ID: 38438446
[TBL] [Abstract][Full Text] [Related]
14. Novel multi-target compounds in the quest for new chemotherapies against Alzheimer's disease: An experimental and theoretical study.
Martínez A; Zahran M; Gomez M; Cooper C; Guevara J; Ekengard E; Nordlander E; Alcendor R; Hambleton S
Bioorg Med Chem; 2018 Sep; 26(17):4823-4840. PubMed ID: 30181028
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's Disease "Non-amyloidogenic" p3 Peptide Revisited: A Case for Amyloid-α.
Kuhn AJ; Abrams BS; Knowlton S; Raskatov JA
ACS Chem Neurosci; 2020 Jun; 11(11):1539-1544. PubMed ID: 32412731
[TBL] [Abstract][Full Text] [Related]
16. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
Atsmon-Raz Y; Miller Y
ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
[TBL] [Abstract][Full Text] [Related]
17. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.
Salahuddin P; Fatima MT; Abdelhameed AS; Nusrat S; Khan RH
Eur J Med Chem; 2016 May; 114():41-58. PubMed ID: 26974374
[TBL] [Abstract][Full Text] [Related]
18. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
19. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
[TBL] [Abstract][Full Text] [Related]
20. Sequence and structure-based peptides as potent amyloid inhibitors: A review.
Mitra A; Sarkar N
Arch Biochem Biophys; 2020 Nov; 695():108614. PubMed ID: 33010227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
